Of the thousands or even millions of possible drug compounds evaluated for their curative properties, only a few make it to market, according to SRI scientist Walter Moos, who speaks about this process at 6 p.m. Tuesday, Oct. 12, at SRI International headquarters at Middlefield Road and Ringwood Avenue in Menlo Park.
At the October Cafe Scientifique, Mr. Moos will note that the Food and Drug Administration approved 50 drugs in 1996 and only 26 in 2009.
Why? Profits at big pharmaceutical companies continue to rely on older drugs. To improve the bottom line, drug companies are cutting research and development budgets, Mr. Moos says.
Go to cafescisv.org for directions, information on parking, and other details.